|
| 36936213 | Hepatitis B virus and hepatitis D virus infection in women with or at risk for HIV infection in the United States. | Front Med (Lausanne) | 2023 |
| 37610358 | Risk of Hepatocellular Carcinoma in People with HIV in the United States, 2001-2019. | | 2023 |
| 37347978 | Genotype Frequencies in Asian Populations Support Shorter Duration Therapy with Sofosbuvir-Based Hepatitis C Virus Regimens to Increase the Number Cured. | | 2023 |
| 36573283 | No Association of IFNL4 Genotype With Opportunistic Infections and Cancers Among Men With Human Immunodeficiency Virus 1 Infection. | Clin Infect Dis | 2023 |
| 33549870 | Declining US Hepatocellular Carcinoma Rates, 2014-2017. | Clinical Gastroenterology and Hepatology | 2022 |
| 35585257 | The role of IFNL4 in liver inflammation and progression of fibrosis. | Genes and Immunity | 2022 |
| 36358697 | Association between Immunologic Markers and Cirrhosis in Individuals from a Prospective Chronic Hepatitis C Cohort. | Cancers (Basel) | 2022 |
| 34497603 | Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects. | Frontiers in Immunology | 2021 |
| 34286851 | Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals. | Aliment Pharmacol Ther | 2021 |
| 33720473 | Death certificates compared to SEER-Medicare data for surveillance of liver cancer mortality due to hepatitis B or hepatitis C infection. | Journal of Viral Hepatitis | 2021 |
| 33119750 | A Multiancestry Sex-Stratified Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus. | J Infect Dis | 2021 |
| 34788130 | The Impact of IFNλ4 on the Adaptive Immune Response to SARS-CoV-2 Infection. | Journal of Interferon and Cytokine Research | 2021 |
| 34782638 | Association between immunologic markers and cirrhosis in individuals with chronic hepatitis B. | Sci Rep | 2021 |
| 31504644 | Metabolic Changes in Chronic Hepatitis C Patients Who Carry IFNL4-οG and Achieve Sustained Virologic Response With Direct-Acting Antiviral Therapy. | Journal of Infectious Diseases | 2020 |
| 31962125 | Recent Decline in Hepatocellular Carcinoma Rates in the United States. | Gastroenterology | 2020 |
| 31846709 | IFNL4: Notable variants and associated phenotypes. | Gene | 2020 |
| 32301957 | Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019. | Clinical Infectious Diseases | 2020 |
| 32289152 | COVID-19 and emerging viral infections: The case for interferon lambda. | Journal of Experimental Medicine | 2020 |
| 32474310 | Prediagnostic serum polychlorinated biphenyl concentrations and primary liver cancer: A case-control study nested within two prospective cohorts. | Environ Res | 2020 |
| 32962868 | Cirrhotic controls in a pooled analysis of hepatitis D and hepatocellular carcinoma. | J Hepatol | 2020 |
| 33230236 | Correction: Multi-ancestry fine mapping of interferon lambda and the outcome of acute hepatitis C virus infection. | Genes Immun | 2020 |
| 32506469 | Genetic Determinants of Cirrhosis and Hepatocellular Carcinoma Due to Fatty Liver Disease: What's the Score? | Hepatology | 2020 |
| 30661282 | Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia. | J Viral Hepat | 2019 |
| 31711627 | CCR5-ο32 and IFNL4-οG/TT. | Clinical Therapeutics | 2019 |
| 30593799 | Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus. | Gastroenterology | 2019 |
| 30287169 | Genetic Factors That Affect Spontaneous Clearance of Hepatitis C or B Virus, Response to Treatment, and Disease Progression. | Gastroenterology | 2019 |
| 30980394 | Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013. | Cancer | 2019 |
| 30701531 | Prediagnostic serum organochlorine insecticide concentrations and primary liver cancer: A case-control study nested within two prospective cohorts. | Int J Cancer | 2019 |
| 31478837 | What makes the hepatitis C virus evolve? | eLife | 2019 |
| 31161939 | What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection? | Journal of Interferon and Cytokine Research | 2019 |
| 30998425 | Meeting Overview: Interferon Lambda-Disease Impact and Therapeutic Potential. | J Interferon Cytokine Res | 2019 |
| 29800369 | Hepatitis D Viremia Among Injection Drug Users in San Francisco. | Journal of Infectious Diseases | 2018 |
| 29866411 | Impact of IFNL4-â¿¿G genotype on sustained virologic response in hepatitis C genotype 1 patients treated with direct-acting antivirals. | Diagnostic Microbiology and Infectious Disease | 2018 |
| 29396075 | Beasley's 1981 paper: The power of a well-designed cohort study to drive liver cancer research and prevention. | Cancer Epidemiology | 2018 |
| 29152758 | The role of genetics in hepatic fibrosis among hepatitis C virus patients. | Hepatology | 2018 |
| 28100007 | Race or genetic makeup for hepatitis C virus treatment decisions? | Hepatology | 2017 |
| 28541547 | Relationship of Genotype for HLA B*57 and IFNL4 With Disease Progression in Female HIV Controllers. | Clinical Infectious Diseases | 2017 |
| 28802815 | Shortening the duration of therapy for chronic hepatitis C infection. | Lancet Gastroenterology and Hepatology, The | 2017 |
| 29159388 | Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus. | Annals of Internal Medicine | 2017 |
| 29107709 | IFNL4 Genotype Is Associated With Virologic Relapse After 8-Week Treatment With Sofosbuvir, Velpatasvir, and Voxilaprevir. | Gastroenterology | 2017 |
| 27832143 | Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials. | PLoS One | 2016 |
| 27183178 | Association of Hepatitis C Virus Infection With CD4/CD8 Ratio in HIV-Positive Women. | Journal of acquired immune deficiency syndromes (1999) | 2016 |
| 26474163 | No scientific basis to restrict 8 weeks of treatment with ledipasvir/sofosbuvir to patients with hepatitis C virus RNA <6,000,000 IU/mL. | Hepatology | 2016 |
| 26115445 | Association of IFNL3 and IFNL4 polymorphisms with liver-related mortality in a multiracial cohort of HIV/HCV-coinfected women. | J Viral Hepat | 2015 |
| 26186989 | Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance. | J Hepatol | 2015 |
| 26431156 | Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes. | PLoS One | 2015 |
| 26509180 | Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C. | Open Forum Infect Dis | 2015 |
| 24786669 | IFN-λ4: the paradoxical new member of the interferon lambda family. | Journal of Interferon and Cytokine Research | 2014 |
| 25734178 | Subgroup differences in response to 8 weeks of ledipasvir/sofosbuvir for chronic hepatitis C. | Open Forum Infect Dis | 2014 |
| 23956438 | Association of the IFNL4-οG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus. | J Infect Dis | 2014 |